Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.

Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Source: www.neurostartms.com
Company: Neuronetics

Image by Courtesy of Neuronetics

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives